Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
Biomolecules · 06.01.2025 · 15 (1) · 71
DOI: 10.3390/biom15010071 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 06.01.2025. Verfasst von Kang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou 311402, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Epigenesis, Genetic, Neoplasms, Stromal Cells. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The tumor microenvironment (TME) plays a pivotal role in neoplastic initiation and progression. Epigenetic machinery, governing the expression of core oncogenes and tumor suppressor genes in transformed cells, significantly contributes to tumor development at both primary and distant sites. Recent studies have illuminated how epigenetic mechanisms integrate external cues and downstream signals, altering the phenotype of stromal cells and immune cells. This remolds the area surrounding tumor cells, ultimately fostering an immunosuppressive microenvironment. Therefore, correcting the TME by targeting the epigenetic modifications holds substantial promise for cancer treatment. This review synthesizes recent research that elucidates the impact of specific epigenetic regulations—ranging from DNA methylation to histone modifications and chromatin remodeling—on stromal and immune cells within the TME. Notably, we highlight their functional roles in either promoting or restricting tumor progression. We also discuss the potential applications of epigenetic agents for cancer treatment, envisaging their ability to normalize the ecosystem. This review aims to assist researchers in understanding the dynamic interplay between epigenetics and the TME, paving the way for better epigenetic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou 311402, China.
- Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Han…
- Department of Drug Clinical Trial Institution, Huzhou Central Hospital, Huzhou 313000, China.
- Westlake Laboratory of Life Sciences and Biomedicine of Zhejiang Province, Westlake University, Hangzhou 310024, China.
ORCID-Profile: Kang Liu
Zitieren
APA
Liu, K., Li, Y., Shen, M., Xu, W., Wu, S., Yang, X., Zhang, B., & Lin, N. (2025). Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment. Biomolecules, 15(1), 71. https://doi.org/10.3390/biom15010071
Vancouver
Liu K, Li Y, Shen M, Xu W, Wu S, Yang X, et al. Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment. Biomolecules. 2025;15(1):71. doi:10.3390/biom15010071
BibTeX
@article{Liu2025,
author = {Liu, Kang and Li, Yue and Shen, Minmin and Xu, Wei and Wu, Shanshan and Yang, Xinxin and Zhang, Bo and Lin, Nengming},
title = {Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {1},
pages = {71},
doi = {10.3390/biom15010071}
}
EUVIMED